Journal of Antimicrobial Chemotherapy (2001) 47, 421-429
© 2001 The British Society for Antimicrobial Chemotherapy
The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients
a Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Sha Tin, Hong Kong, China; b Intensive Care Facility, Royal Brisbane Hospital and Division of Anaesthesiology and Intensive Care, University of Queensland, Australia
The aim of this study was to determine the pharmacokinetic profile of the normal recommended dose of ceftriaxone in critically ill patients and to establish whether the current daily dosing recommendation maintains plasma concentrations adequate for antibacterial efficacy. Ceftriaxone at a recommended dose of 2 g iv was administered od to 12 critically ill patients with severe sepsis and normal serum creatinine concentrations. Blood samples were taken at pre-determined intervals over the first 24 h and on day 3 for measurement of ceftriaxone concentrations. There was wide variability in drug disposition, explained by the presence of variable renal function and identified by the measurement of creatinine clearance. In nine patients with normal renal function, there was a high level of creatinine clearance (mean ± S.D., 41 ± 12 mL/min) and volume of distribution (20 ± 3.3 L), which resulted in an elimination half-life of 6.4 ± 1.1 h. In comparison with normal subjects, ceftriaxone clearance was increased 100%, volume of distribution increased 90% and the elimination half-life was similar. Three patients had substantially suboptimal plasma ceftriaxone concentrations. We confirm previous findings that ceftriaxone clearance in critically ill patients correlates with renal clearance by glomerular filtration. The elimination half-life is prolonged (21.4 ± 9.8 h) in critically ill patients with renal failure when compared with previously published data in non-critically ill patients with renal failure. We conclude that in critically ill patients with normal renal function, inadequate plasma concentrations may result following od bolus dosing of ceftriaxone. Drug accumulation may occur in critically ill patients with renal failure.
* Corresponding author. Tel: +852-2632-2735; Fax: +852-2637-2422; E-mail: gavinmjoynt{at}cuhk.edu.hk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. M. M. Y. Li, C. D. Gomersall, G. Choi, Q. Tian, G. M. Joynt, and J. Lipman A systematic review of antibiotic dosing regimens for septic patients receiving continuous renal replacement therapy: do current studies supply sufficient data? J. Antimicrob. Chemother., November 1, 2009; 64(5): 929 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L Crandon, J. L Kuti, R. N Jones, and D. P Nicolau Comparison of 2002-2006 OPTAMA Programs for US Hospitals: Focus on Gram-Negative Resistance Ann. Pharmacother., February 1, 2009; 43(2): 220 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Roberts, R. Boots, C. M. Rickard, P. Thomas, J. Quinn, D. M. Roberts, B. Richards, and J. Lipman Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study J. Antimicrob. Chemother., February 1, 2007; 59(2): 285 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Burkhardt, V. Kumar, D. Katterwe, J. Majcher-Peszynska, B. Drewelow, H. Derendorf, and T. Welte Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration J. Antimicrob. Chemother., February 1, 2007; 59(2): 277 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Schwartz Potential Mechanisms for Mortality Reduction Associated with Combination Antibiotic Therapy among Severely Ill Patients with Pneumococcal Bacteremia Am. J. Respir. Crit. Care Med., December 1, 2005; 172(11): 1472a - 1473. [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Zuppa, P. C. Adamson, J. T. Mondick, L. A. Davis, D. A. Maka, M. Narayan, C. Nicholson, D. Patel, K. R. Collison, and J. S. Barrett Drug Utilization in the Pediatric Intensive Care Unit: Monitoring Prescribing Trends and Establishing Prioritization of Pharmacotherapeutic Evaluation of Critically Ill Children J. Clin. Pharmacol., November 1, 2005; 45(11): 1305 - 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Joukhadar, P. Dehghanyar, F. Traunmuller, R. Sauermann, B. Mayer-Helm, A. Georgopoulos, and M. Muller Increase of Microcirculatory Blood Flow Enhances Penetration of Ciprofloxacin into Soft Tissue Antimicrob. Agents Chemother., October 1, 2005; 49(10): 4149 - 4153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Cook Pharmacokinetic Alterations of Antimicrobials in the Critically Ill Journal of Pharmacy Practice, April 1, 2005; 18(2): 75 - 83. [Abstract] [PDF]
|
|
|
|
|
|
R. Gattringer, E. Urbauer, F. Traunmuller, M. Zeitlinger, P. Dehghanyar, P. Zeleny, W. Graninger, M. Muller, and C. Joukhadar Pharmacokinetics of Telithromycin in Plasma and Soft Tissues after Single-Dose Administration to Healthy Volunteers Antimicrob. Agents Chemother., December 1, 2004; 48(12): 4650 - 4653. [Abstract] [Full Text] [PDF]
|
|